Testing Dabrafenib and Trametinib With or Without Hydroxychloroquine in Stage IIIC or IV BRAF V600E/K Melanoma

Clinical trial NCT04527549 · TERMINATED

Trial details

NCT number: NCT04527549
Sponsor: ECOG-ACRIN Cancer Research Group
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Clinical Stage IV Cutaneous Melanoma AJCC v8 Locally Advanced Melanoma Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Pathologic Stage IV Cutaneous Melanoma AJCC v8 Unresectable Melanoma

Start date: 2021-06-01
Primary completion: 2024-01-08
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.